Holen Sie sich die Stockscreener-App
82.33
1.86%
-1.56
Handel nachbörslich:
82.33
Schlusskurs vom Vortag:
$83.89
Offen:
$81.27
24-Stunden-Volumen:
582.30K
Relative Volume:
2.02
Marktkapitalisierung:
$907.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.66%
1M Leistung:
-12.89%
6M Leistung:
-11.70%
1J Leistung:
-6.78%
1-Tages-Spanne:
$79.83
$84.24
1-Wochen-Bereich:
$79.83
$90.85
52-Wochen-Spanne:
$79.83
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Firmenname
Vaneck Pharmaceutical Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
82.33 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
247.66 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
504.38 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
506.38 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
198.98 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
423.69 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Aktie (PPH) Neueste Nachrichten
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Big Pharma higher after tariff exemption despite ongoing uncertainties - MSN
Raymond James Financial Inc. Invests $1.32 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Big Pharma drops sharply ahead of Trump’s tariff announcement - MSN
U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs - Seeking Alpha
Commonwealth Equity Services LLC Buys 631 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by US Bancorp DE - Defense World
Assetmark Inc. Has $86,000 Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
SBI Securities Co. Ltd. Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Jones Financial Companies Lllp Acquires 5,408 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
AI-Driven Semiconductor Growth - VanEck
Atria Wealth Solutions Inc. Has $304,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novartis pulls back after report on Emasan share offering - MSN
A Better Way to Equal Weight? - VanEck
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Cencora Stock Outlook: Is Wall Street Bullish or Bearish? - TradingView
Top Semiconductor Companies to Watch in 2025 - VanEck
Five ETFs to invest in to hedge against policy uncertainty in 2025 - TradingView
DeepSeek’s Disruption: The Impact on Nvidia and the Semiconductor Industry - VanEck
How to profit from AI innovation in 2025 - Equities News
Is Wall Street Bullish or Bearish on AbbVie Stock? - Inkl
2025 Semiconductor Outlook: Investor Roadmap - VanEck
JPMorgan Chase & Co. Has $907,000 Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Barclays PLC Sells 3,263 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Is Investing in the WisdomTree Cloud Computing ETF (WCLD) a Smart Move - espeaks.co.uk
Gold in 2024: Central Bank Demand, Rising Prices and the Equity Disconnect - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Is Investing in the Invesco Semiconductors ETF (PSI) a Smart Move - espeaks.co.uk
What Trump's Presidency Will Mean for Bitcoin - VanEck
Tech Investing in 2025: Emerging Trends and Market Opportunities - VanEck
Annual ETF Highlights: A Dive Into the Best and Worst of 2024 - VanEck
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
Taking a Look Under the Hood of VanEck’s Video Gaming and Esports Strategy - VanEck
The New Era of Defense: Global Trends and Investment Opportunities - VanEck
Sanctuary Advisors LLC Sells 41,736 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Investment Opportunities in SMRs: The Future of Nuclear Power - VanEck
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Jane Street Group LLC - Defense World
Finanzdaten der Vaneck Pharmaceutical Etf-Aktie (PPH)
Es liegen keine Finanzdaten für Vaneck Pharmaceutical Etf (PPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):